236 results on '"Marchiò C"'
Search Results
2. Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022
3. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
4. ESMO Recommendations on clinical reporting of genomic test results for solid cancers
5. Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses
6. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
7. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
8. Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
9. C42 - The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients
10. Chemotherapy with or without trastuzumab
11. Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses
12. LBA91 TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T+O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments
13. 223P Artificial intelligence-based pathomics biomarker predict primary resistance to first-line treatment in metastatic colorectal cancers
14. The genomic profile of HER2-amplified breast cancers: the influence of ER status#
15. ESR1 amplification in endometrial carcinomas: hope or hyperbole?#
16. Hereditary breast cancer: from molecular pathology to tailored therapies
17. Nestin is expressed in basal-like and triple negative breast cancers
18. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast#
19. Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status
20. Recommendations for using molecular assays on liquid biopsy: the first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC
21. Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
22. A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling
23. 1206P HER2 copy number variation (CNV), HER2 expression and primary resistance mechanisms in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction cancer (mGC/GEJC) receiving first-line chemotherapy (CT) + trastuzumab (T) +/- pertuzumab (P) in the JACOB trial
24. PO-466 PI3K-C2A regulates mitotic spindle assembly and chemotherapy response in breast cancer
25. P2.09-003 Dissecting the Immune Environment in Malignant Pleural Mesothelioma: Results from a Prospective Assessment
26. The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients
27. Uterine carcinosarcomas and metaplastic breast carcinomas: Genetically related cancers?
28. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
29. Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification
30. SPOT-003 Thymidylate synthase maintains the undifferentiated state of aggressive breast cancers
31. Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis
32. Il carcinoma in situ micropapillare della mammella. Correlazioni anatomo-patologiche e cliniche
33. P.14.6 ENDOSCOPIC ULTRASOUND-GUIDED SAMPLING OF MEDIASTINAL, PANCREATIC AND GASTROINTESTINAL LESIONS: FINE NEEDLE ASPIRATION (EUS-FNA) AND SAMPLING WITHOUT ASPIRATION (SO-CALLED “CAROTAGE”)
34. P.1.212: YIELD OF ENDOSCOPIC ULTRASOUND (EUS) AND EUS-FNA IN THE DIAGNOSIS AND FOLLOW-UP OF INTRADUCTAL PAPILLARY MUCINOUS TUMORS: A SINGLE CENTRE EXPERIENCE
35. ESR1amplification in endometrial carcinomas: hope or hyperbole?
36. 136IN - How to Quantify Immuohistochemical Slides
37. Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer
38. Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification
39. Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
40. ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
41. CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report
42. Classification of pulmonary neuroendocrine tumors: new insights
43. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes
44. 'To be or not to be in a good shape': diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer
45. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.
46. Glyoxal acid-free (GAF) histological fixative is a suitable alternative to formalin: results from an open-label comparative non-inferiority study.
47. Enhancing breast cancer screening with urinary biomarkers and Random Forest supervised classification: A comprehensive investigation.
48. Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer.
49. Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations.
50. Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.